Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Detrusor Muscle Hyperactivity
Interventions
BIOLOGICAL

Botulinum toxin type A

750 U intra detrusor injection on Day 1 (single dose)

DRUG

Placebo

Intra detrusor injection on Day 1 (single dose)

Trial Locations (17)

Unknown

Faculty Hospital Motol, Prague

THOMAYER Faculty Hospital, Prague

Hopital Raymond Poincaré, Garches

Hopital HURIET, Lille

Hôpital Lyon Sud -Hospices Civils de Lyon, Lyon

Hopital de la conception, Marseille

CHU Hotel Dieu, Nantes

Groupe Hospitalier La Pitié Salpetriere, Paris

Hopital Tenon, Paris

CMRRF Kerpape, Ploemeur

CHU Rouen - Hopital Charles Nicolle, Rouen

Nouvel Hopital civil de Strasbourg, Strasbourg

CHU Toulouse - Hopital Rangueil, Toulouse

Universitätsklinik Kiel, Kiel

Städtisches Klinikum Neunkirchen, Neunkirchen

Ospedale Careggi, Florence

NZOZ Centrum Medyczne Mazovia, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY